9 withdrawn. 9 Phase 4.
By phase and status
Follow Hepatitis B: new trials by email Literature Review of Hepatitis B trials Research Report on Hepatitis B
Trials (filtered) newest first · largest first
All 9 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)
Blood sampling - Hepatitis B, Hepatitis A | Phase 4 | Withdrawn | | 2015-05-01 | 2015-11-18 |
A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)
Tenofovir, Pegylated interferon alpha-2b - Hepatitis B | Phase 4 | Withdrawn | | 2013-08-01 | 2013-09-19 |
A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.
entecavir, peginterferon alfa-2a [Pegasys], placebo - Hepatitis B, Chronic | Phase 4 | Withdrawn | | 2010-09-18 | 2017-02-17 |
Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders
Twinrix - Hepatitis B | Phase 4 | Withdrawn | | 2010-04-01 | 2020-06-01 |
Entecavir Plus Adefovir in Lamivudine-Resistant Patients
Lamivudine, Entecavir, Adefovir - Hepatitis B, Chronic | Phase 4 | Withdrawn | | 2009-12-01 | 2015-09-01 |
Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients
maraviroc, etravirine - Hepatitis B, Human Immunodeficiency Virus | Phase 4 | Withdrawn | | 2009-03-01 | 2012-01-19 |
Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B
telbivudine, adefovir dipivoxil - Chronic Hepatitis B | Phase 4 | Withdrawn | | 2007-11-01 | 2012-05-02 |
Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B
Lamivudine, Telbivudine - Hepatitis B, Chronic | Phase 4 | Withdrawn | 40 | | 2009-04-20 |
Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy
Telbivudine, Adefovir, Tenofovir - Chronic Hepatitis B | Phase 4 | Withdrawn | | | 2015-03-09 |
Narrower conditions
Hepatitis B, Chronic (5) · Acquired Immunodeficiency Syndrome (1) · Hepatitis A (1) · Hepatitis C, Chronic (1)
Broader conditions
Blood-Borne Infections (9) · Communicable Diseases (9) · DNA Virus Infections (9) · Digestive System Diseases (9) · Hepadnaviridae Infections (9) · Hepatitis (9) · Hepatitis, Viral, Human (9) · Infections (9) · Liver Diseases (9) · Virus Diseases (9) · Chronic Disease (6) · Disease Attributes (6) · Hepatitis, Chronic (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6)
Interventions
Telbivudine (3) · Lamivudine (2) · Tenofovir (2) · adefovir (2) · adefovir dipivoxil (2) · entecavir (2) · Blood Specimen Collection (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Maraviroc (1) · etravirine (1) · lipoarabinomannan (1) · peginterferon alfa-2a (1) · peginterferon alfa-2b (1) · twinrix (1)
Sponsors
Bristol-Myers Squibb (1) · GlaxoSmithKline (1) · Hoffmann-La Roche (1) · Merck Sharp & Dohme LLC (1) · Mount Sinai Hospital, Canada (1) · Novartis (1) · Novartis Pharmaceuticals (1) · University of Ulm (1) · ViiV Healthcare (1)
Countries
Canada (2) · United States (2) · Czechia (1) · Germany (1) · Poland (1)
Top investigators
Allison J McGeer, MD MSc (1) · Nektarios Dikopoulos, MD (1) · Todd C Lee, MD (1)
NIH funding
2009 (1)